Derek Barratt

1.5k total citations
20 papers, 1.0k citations indexed

About

Derek Barratt is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Derek Barratt has authored 20 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 5 papers in Oncology and 3 papers in Organic Chemistry. Recurrent topics in Derek Barratt's work include DNA Repair Mechanisms (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and Cancer therapeutics and mechanisms (3 papers). Derek Barratt is often cited by papers focused on DNA Repair Mechanisms (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and Cancer therapeutics and mechanisms (3 papers). Derek Barratt collaborates with scholars based in United Kingdom, United States and Germany. Derek Barratt's co-authors include Philip P. Duce, Peter J. Taylor, Jeffrey J. Morris, Michael H. Abraham, David V. Prior, Mike Berger, Chris J. Novotny, Teresa Klinowska, Neal Rosen and Masanori Okaniwa and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Derek Barratt

18 papers receiving 994 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Derek Barratt United Kingdom	10	606	246	205	192	98	20	1.0k
Kirubhagaran Ravichandran United States	9	733 1.2×	253 1.0×	96 0.5×	223 1.2×	77 0.8×	14	1.6k
Keizo Koya United States	19	627 1.0×	205 0.8×	406 2.0×	102 0.5×	33 0.3×	31	1.2k
Siyan Liao China	20	714 1.2×	448 1.8×	357 1.7×	79 0.4×	47 0.5×	52	1.3k
Christine Luong United States	16	549 0.9×	262 1.1×	387 1.9×	300 1.6×	41 0.4×	19	1.5k
John Eksterowicz United States	16	374 0.6×	208 0.8×	272 1.3×	63 0.3×	87 0.9×	26	886
Ted W. Johnson United States	18	790 1.3×	156 0.6×	395 1.9×	64 0.3×	74 0.8×	28	1.6k
Aijun Shen China	23	1.0k 1.7×	353 1.4×	181 0.9×	255 1.3×	81 0.8×	39	1.6k
Ana Conejo‐García Spain	20	599 1.0×	127 0.5×	404 2.0×	163 0.8×	76 0.8×	61	998
Vandana Sridhar United States	16	742 1.2×	462 1.9×	72 0.4×	122 0.6×	128 1.3×	25	1.5k
Matthew W. D. Perry Sweden	19	834 1.4×	179 0.7×	513 2.5×	44 0.2×	68 0.7×	34	1.4k

Countries citing papers authored by Derek Barratt

Since Specialization

Citations

This map shows the geographic impact of Derek Barratt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Derek Barratt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Derek Barratt more than expected).

Fields of papers citing papers by Derek Barratt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Derek Barratt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Derek Barratt. The network helps show where Derek Barratt may publish in the future.

Co-authorship network of co-authors of Derek Barratt

This figure shows the co-authorship network connecting the top 25 collaborators of Derek Barratt. A scholar is included among the top collaborators of Derek Barratt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Derek Barratt. Derek Barratt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Martins, Carla P., Satyajit K. Mitra, Katherine Young, et al.. (2025). Abstract ND11: AZD0022: a potent, oral KRASG12D-selective inhibitor that drives robust pathway inhibition and anti-tumour activity in KRASG12D models. Cancer Research. 85(8_Supplement_2). ND11–ND11. 2 indexed citations

Breckels, Lisa M., et al.. (2024). Global Proteomics Indicates Subcellular-Specific Anti-Ferroptotic Responses to Ionizing Radiation. Molecular & Cellular Proteomics. 24(1). 100888–100888. 4 indexed citations

Kantae, Vasudev, Radosław Polański, Hilary Lewis, et al.. (2022). Accelerating the Validation of Endogenous On-Target Engagement and In Cellulo Kinetic Assessment for Covalent Inhibitors of KRAS ^G12C in Early Drug Discovery. ACS Chemical Biology. 17(8). 2366–2376. 6 indexed citations

Goldberg, Frederick W., Attilla Ting, David T. Beattie, et al.. (2022). Optimization of hERG and Pharmacokinetic Properties for Basic Dihydro-8H-purin-8-one Inhibitors of DNA-PK. ACS Medicinal Chemistry Letters. 13(8). 1295–1301. 7 indexed citations

McWilliams, Lisa, et al.. (2021). A Novel High-Throughput FLIPR Tetra–Based Method for Capturing Highly Confluent Kinetic Data for Structure–Kinetic Relationship Guided Early Drug Discovery. SLAS DISCOVERY. 26(5). 684–697. 5 indexed citations

Hoyt, Emily, Morgan Thomas, Marianne Schimpl, et al.. (2020). Alkynyl Benzoxazines and Dihydroquinazolines as Cysteine Targeting Covalent Warheads and Their Application in Identification of Selective Irreversible Kinase Inhibitors. Journal of the American Chemical Society. 142(23). 10358–10372. 57 indexed citations

Goldberg, Frederick W., M. Raymond V. Finlay, Attilla Ting, et al.. (2019). The Discovery of 7-Methyl-2-[(7-methyl[1,2,4]triazolo[1,5-a]pyridin-6-yl)amino]-9-(tetrahydro-2H-pyran-4-yl)-7,9-dihydro-8H-purin-8-one (AZD7648), a Potent and Selective DNA-Dependent Protein Kinase (DNA-PK) Inhibitor. Journal of Medicinal Chemistry. 63(7). 3461–3471. 66 indexed citations

Goldberg, Frederick W., Elaine Cadogan, David A. Beattie, et al.. (2019). Abstract DDT01-02: Discovery and first structural disclosure of AZD7648: A potent and selective DNA-PK inhibitor. DDT01–2. 1 indexed citations

Goldberg, Frederick W., Elaine Cadogan, David T. Beattie, et al.. (2019). Abstract DDT01-02: Discovery and first structural disclosure of AZD7648: A potent and selective DNA-PK inhibitor. Cancer Research. 79(13_Supplement). DDT01–2. 1 indexed citations

10.

Rodrik-Outmezguine, Vanessa, Masanori Okaniwa, Zhan Yao, et al.. (2016). Overcoming mTOR resistance mutations with a new-generation mTOR inhibitor. Nature. 534(7606). 272–276. 341 indexed citations

11.

Rodrik-Outmezguine, Vanessa, Masanori Okaniwa, Zhan Yao, et al.. (2016). Abstract 2147: Overcoming mTOR resistance mutations with a new generation mTOR inhibitor. Cancer Research. 76(14_Supplement). 2147–2147.

12.

Rodrik-Outmezguine, Vanessa, Zhan Yao, Liqun Cai, et al.. (2014). Abstract 1726: Acquired resistance to rapamycin and mTOR kinase inhibitors is mediated by non-overlapping mutations in distinct sites in the mTOR protein. Cancer Research. 74(19_Supplement). 1726–1726.

13.

Smith, Graeme, Derek Barratt, Rachel Rowlinson, Janice Nickson, & Robert Tonge. (2005). Development of a high‐throughput method for preparing human urine for two‐dimensional electrophoresis. PROTEOMICS. 5(9). 2315–2318. 35 indexed citations

14.

Rowsell, Siân, Claire A. Minshull, Sarah Brockbank, et al.. (2002). Crystal Structure of Human MMP9 in Complex with a Reverse Hydroxamate Inhibitor. Journal of Molecular Biology. 319(1). 173–181. 211 indexed citations

15.

Needham, M., Derek Barratt, M. Anderson, et al.. (1996). High Level Expression of Human MCP-1 Using the LCR/MEL Expression System. Protein Expression and Purification. 7(2). 173–182. 5 indexed citations

16.

Breeze, Alexander L., et al.. (1996). Structure of a specific peptide complex of the carboxy-terminal SH2 domain from the p85 alpha subunit of phosphatidylinositol 3-kinase.. The EMBO Journal. 15(14). 3579–3589. 48 indexed citations

17.

Needham, M., Nicholas C. Sturgess, R. Wilson, et al.. (1996). Monocyte chemoattractant protein-1: receptor interactions and calcium signaling mechanisms. Journal of Leukocyte Biology. 60(6). 793–803. 10 indexed citations

18.

Abraham, Michael H., Philip P. Duce, David V. Prior, et al.. (1989). Hydrogen bonding. Part 9. Solute proton donor and proton acceptor scales for use in drug design. Journal of the Chemical Society Perkin Transactions 2. 1355–1355. 186 indexed citations

19.

Abraham, Michael H., et al.. (1986). Hydrogen bonding. Part 1.—Equilibrium constants and enthalpies of complexation for monomeric carboxylic acids with N-methylpyrrolidinone in 1,1,1-trichloroethane. Journal of the Chemical Society Faraday Transactions 1 Physical Chemistry in Condensed Phases. 82(11). 3501–3501. 22 indexed citations

20.

Sharom, Frances J., Derek Barratt, & Chris W.M. Grant. (1977). Glycophorin and the concanavalin A receptor of human erythrocytes: their receptor function in lipid bilayers.. Proceedings of the National Academy of Sciences. 74(7). 2751–2755. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact